Haemangioma Treatment in Jaipur

What Haemangioma Is and How It Happens

A haemangioma is a benign tumour made up of small blood vessels. It is the most common benign tumour of infancy. These marks appear shortly after birth, usually in the first few weeks of life. They grow quickly during the first few months, a phase called the proliferative phase.

During this time the vessels are disorganised and composed of immature endothelial cells. After the growth phase the haemangioma enters a slow involution phase. The vessels mature and enlarge but reduce in number, and fat, fibroblasts and connective tissue replace the vascular tissue. Most infantile haemangiomas do not require therapy and get better without any treatment.

Port-wine stains are different. They are congenital vascular malformations that are present at birth. Unlike haemangiomas, they do not involute spontaneously. They may become progressively more disfiguring as the child grows. When a port-wine stain affects the face, eyes and central nervous system it may be part of Sturge-Weber syndrome.

Symptoms and Warning Signs That Need Urgent Care

Many haemangiomas cause no problems. Treatment is considered when the lesion is life-threatening, ulcerated, associated with congenital anomalies, at risk of scarring, or obstructs the airway. A haemangioma near the eye may affect vision. Lesions can bleed, become infected and painful. If any of these problems happen, treatment with propranolol can improve symptoms.

Urgent medical attention is needed if your child shows signs of low blood sugar while on propranolol: irritability or restlessness, tiredness or inactivity, increased sweating, shakiness, or a big increase or drop in hunger. Also seek care immediately if your child is not eating, vomiting, unusually tired, cool or clammy to the touch, or wheezing and having trouble breathing. If a dose is vomited, skip that dose and do not re-dose or double up.

Causes and Who Is at Higher Risk

The precise cause of haemangioma is uncertain but may be related to anomalous vessels. Both angiogenesis and vasculogenesis have been proposed as mechanisms contributing to the neovascularisation in haemangioma tumours. Haemangioma progenitor or stem cells, endothelial cells and pericytes have been isolated as cells comprising the haemangioma. Molecular pathways within these cells are implicated in driving the pathogenesis.

Propranolol is not suitable for every child. It should not be given to children with certain health problems, for example asthma. Your doctor will discuss this with you before starting any treatment. Some asthma medicines will not work if your child is taking propranolol. Teething gels containing lidocaine should be avoided while taking propranolol. Always ask your doctor before giving any other medicine while your child is on propranolol.

How Haemangioma Is Diagnosed: Examination and Tests

Diagnosis is usually made by clinical examination. The doctor looks at the appearance, location and growth pattern of the lesion. Photographs are often taken to track changes over time. If the haemangioma is deep or near vital structures, imaging such as ultrasound or MRI may be used to assess the extent.

For infants starting propranolol, a baseline assessment includes weight, blood pressure, heart rate, and sometimes blood glucose. The child is examined by a doctor who checks the heart and chest. Close follow-up in the first weeks of life is crucial to identify at-risk haemangiomas early.

Treatment Options Without Surgery and When Surgery Is Advised

Oral propranolol is now the first-line treatment for infantile haemangioma that needs therapy. It helps stop the haemangioma from growing and can speed up the shrinking process. Treatment should start as early as possible during the growing phase, normally until the child is one year of age. The dose is chosen carefully and adjusted according to weight and response.

The medicine is given twice a day with food to prevent low blood sugar. A minimum of six months of therapy is usually recommended. The duration of propranolol therapy ranges from two to twelve months.

Topical timolol maleate gel or solution may be prescribed for thin or superficial haemangiomas. It is generally preferred to imiquimod. Combined oral and topical beta-blocker therapy has been reported as successful for superficial periocular lesions in the early proliferative stage.

Oral corticosteroids may be used if there are contraindications to propranolol or if the response is inadequate. Intralesional corticosteroid injection can be recommended for focal or bulky lesions in critical locations during proliferation. However, intralesional corticosteroids carry risks such as lid necrosis, depigmentation, fat necrosis, and rarely central retinal artery occlusion after injection of periocular lesions.

Systemic corticosteroids can cause:

• Cushingoid changes
• Growth delay
• Hypertension
• Diabetes
• Rebound growth on stopping

Sirolimus, an mTOR inhibitor, is reserved for treatment-resistant haemangiomas and should be administered only by practitioners experienced with its monitoring requirements and side effects. Oral sirolimus carries increased susceptibility to infection, possible lymphoma risk, and requires therapeutic drug monitoring because of its narrow therapeutic index.

Sclerotherapy with a sclerosant injection is used for venous malformations. Combination of propranolol and sclerotherapy has been reported as effective and safe for infantile parotid haemangiomas.

Surgical excision is considered for well-circumscribed or residual lesions after involution. Surgery on proliferating haemangiomas is potentially hazardous and should be performed only by specially trained surgeons. Laser therapy may be recommended for ulcerated lesions or lesions that obstruct vital structures. Pulsed dye laser is the standard treatment for port-wine stains.

However, very few patients achieve total clearance with pulsed dye laser therapy, and a significant number of lesions fail to respond at all. Recurrence of port-wine stains is frequent because of reformation and reperfusion of blood vessels.

Preparing for haemangioma treatment

Before treatment starts, your doctor will ask about your child's health history and any medicines they take. This includes asthma inhalers, teething gels with lidocaine, or other beta-blockers, because these can interact with propranolol. The doctor will examine the haemangioma, note its size, depth, and location, and check whether it is near the eye, airway, or other vital structures. Photographs are usually taken to track changes over time.

If oral propranolol is planned, your child will be weighed and have their blood pressure, heart rate, and sometimes blood glucose checked before the first dose. The first dose is given in hospital so the team can monitor for any side effects for about four hours. If no problems occur, you can continue the medicine at home twice daily with food.

For sclerotherapy or surgical excision, routine pre-operative blood tests and a fitness check by the anaesthesia team are done. You will be told when to stop eating and drinking before the procedure. Bring any regular medicines, the child's immunisation record, and a comfort item for the waiting period. An attendant should stay with the child throughout the day.

How haemangioma treatment is done

Treatment depends on the type of vascular lesion, its size, depth, location, and whether it is causing problems. Your surgeon or doctor will explain which option suits your child.

• Propranolol medicine: This is the first-line medical treatment for problematic infantile haemangiomas. It is given as a liquid by mouth, usually twice a day with feeds to prevent low blood sugar. The dose is calculated by weight and adjusted as your child grows. Treatment continues through the growing phase, typically until about one year of age. Stopping too early can allow the haemangioma to regrow, but treatment can be restarted if needed.
• Sclerotherapy: A sclerosant medicine is injected into the abnormal veins of a venous malformation to make them shrink and close off. It is done under local or general anaesthesia and takes about 30 to 90 minutes. More than one session may be needed.
• Surgical excision: This is considered for well-defined lesions or for residual tissue after medical treatment has done its work. The operation is done under general anaesthesia and takes 30 to 90 minutes. The surgeon removes the lesion and closes the wound with stitches.
• Sirolimus (topical or oral): This mTOR inhibitor is reserved for complicated or treatment-resistant cases and is given only by doctors experienced in its monitoring requirements. Blood levels must be checked regularly because the drug has a narrow therapeutic index.

On the day of a procedure, you will report to the admission area. For daycare procedures, discharge is usually the same day once your child is eating, drinking, and comfortable.

Risks and possible complications of haemangioma treatment

Most children tolerate propranolol well, but side effects can occur. Common ones include disturbed sleep, tummy ache, cold hands and feet, wheeze or cough, and a slow heart rate. Low blood sugar is rare but serious; signs are irritability, unusual tiredness, sweating, shakiness, or a sudden change in appetite. If you notice these, seek medical help immediately. Propranolol is not started in children with certain conditions such as asthma.

Topical timolol is more potent than oral propranolol and can cause systemic absorption, especially over ulcerated or thick lesions; it is used with caution. Systemic corticosteroids carry risks of Cushingoid changes, growth delay, diabetes, hypertension, infections, and rebound growth when stopped.

Intralesional steroids can cause skin thinning, pigment changes, fat necrosis, and rarely adrenal suppression or retinal artery occlusion if injected near the eye.

Sirolimus increases infection risk and requires regular blood monitoring; long-term use carries a theoretical risk of lymphoma. Interferon alfa is rarely used because it can cause fever, chills, joint pains, retinal vasculopathy, and potentially irreversible spastic diplegia, especially in children under one year.

Sclerotherapy risks include pain, bruising, swelling, skin discolouration, and rarely nerve injury or skin necrosis. Surgical risks include bleeding, infection, wound breakdown, and scarring. Recurrence of port-wine stains after laser treatment is frequent because vessels can reform. In one study, no complications of propranolol or sclerotherapy occurred during the medication period.

Recovery and aftercare for haemangioma treatment

After a daycare procedure such as sclerotherapy or excision, bruising and swelling usually settle in one to two weeks. Your child can eat and drink normally once fully awake. Pain is usually mild and managed with paracetamol syrup if needed. Keep the dressing clean and dry; the nurse will tell you when it can be removed. Stitches, if any, are usually dissolvable or removed at a follow-up visit.

For oral propranolol, give the medicine every 12 hours with a feed or meal. Never double a missed dose; if your child vomits a dose, skip it. Do not give propranolol if your child is fasting for surgery, not eating well, vomiting, unusually tired, cool or clammy, or wheezing.

Your child will be reweighed in clinic every few months and the dose adjusted. Photographs are repeated to track progress.

A minimum of six months of propranolol therapy is typical, and the total duration ranges from two to twelve months. Colour change and softening can appear within days, with involution over weeks. After treatment stops, the haemangioma continues to shrink slowly over years.

Call the hospital or visit the emergency department if your child develops a rash, difficulty breathing, persistent vomiting, extreme drowsiness, cold sweats, or any sign of low blood sugar. For surgical wounds, call if there is increasing redness, swelling, pus, or fever.

Results of haemangioma treatment

In studies, oral propranolol leads to rapid haemangioma shrinkage. Colour change and softening are often seen within 24 hours, and most lesions continue to improve until nearly flat with much less colour. One study reported reductions in both volume and astigmatism for periocular lesions, with only one of 18 children stopping because of side effects.

Propranolol reduced the need for surgery by 61% and for any invasive treatment by 56% in a cohort of 58 children. The mean treatment duration in that study was 7.6 months at 2 mg/kg per day.

Combined propranolol and sclerotherapy for parotid haemangiomas was effective and safe, with satisfied aesthetic outcomes in all patients. The median age at treatment start was about five months, and an average of two sclerotherapy sessions were given.

Systemic corticosteroids show variable response: excellent in about 30%, questionable in 40%, and no response in 30% of patients under close observation. Response rates range from under 40% to over 90% depending on dose, duration, and age at start. Intralesional steroids are most effective at two weeks but may show effect up to two months later.

Oral sirolimus showed a positive response in five of eight treatment-resistant cases in a systematic review. Pulsed dye laser for port-wine stains achieves total clearance in very few patients, and a significant number do not respond at all. Recurrence is frequent because vessels can reform. Surgical excision of involuted lesions is common and generally gives good cosmetic results.

Cost and insurance for haemangioma treatment in Jaipur

The typical price range for haemangioma treatment in India is ₹20,000 to ₹80,000. The final cost depends on the type of treatment (medicine, sclerotherapy, or surgery), the number of sessions needed, the anaesthesia used, and whether any imaging or blood monitoring is required. Medicines such as propranolol syrup are taken for months, so the pharmacy cost adds up over time. Sclerotherapy may need multiple injections. Surgery includes operation theatre charges, anaesthesia, and histology if tissue is sent for examination.

Jaipur Hospital is a NABH-accredited multispeciality hospital. It accepts patients under RGHS, MAA Yojana, CGHS, and a panel of private insurers and TPAs. If you are covered under one of these schemes, bring your card and any pre-authorisation letter. The hospital has a 24-hour emergency department, in-house pharmacy, diagnostic laboratory, and modular operation theatres. For an estimate specific to your child's plan, ask at the admission desk or call the hospital.